Your session is about to expire
← Back to Search
Procedure
New Tube Type for Mechanical Ventilation (RESCUE Trial)
Phase 2
Waitlist Available
Research Sponsored by O. M. Neotech, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients receiving medical care in adult intensive care unit setting
Patients who have been intubated and mechanically ventilated for at least 12 hours
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-extubation
Awards & highlights
RESCUE Trial Summary
This trial will test if a new type of tube can help remove secretions from the lungs of people on mechanical ventilation.
Who is the study for?
This trial is for adults in intensive care who have been on a mechanical ventilator with an endotracheal tube size of 7.0 mm or larger for at least 12 hours. It's not suitable for those intubated with smaller tubes, dual lumen or steel-reinforced tubes, or patients outside adult ICU settings.Check my eligibility
What is being tested?
The study tests the effectiveness and safety of novel airway management catheters (CAM Rescue Cath and CAM Endotrach Cath) to remove secretions from the breathing tubes of patients receiving mechanical ventilation.See study design
What are the potential side effects?
Potential side effects may include discomfort during secretion removal, possible injury to the airway, and risks associated with suctioning such as changes in heart rate or oxygen levels.
RESCUE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently receiving care in an adult intensive care unit.
Select...
I have been on a breathing machine for at least 12 hours.
RESCUE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-extubation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-extubation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
work of breathing
Secondary outcome measures
endotracheal tube patency
Find a Location
Who is running the clinical trial?
O. M. Neotech, Inc.Lead Sponsor
Saint Francis Medical CenterUNKNOWN
Statistical ConsultingUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are not receiving medical care in a place that can provide intensive care for adults.I am currently receiving care in an adult intensive care unit.You have a specific type of breathing tube in place.I have been on a breathing machine for less than 12 hours.You have a breathing tube with a certain size.I have been on a breathing machine for at least 12 hours.You have a breathing tube with a small diameter.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has this course of medication been condoned by the FDA?
"While there is data supporting the safety of this Phase 2 treatment, none of it speaks to efficacy. Therefore, we've rated it a 2."
Answered by AI
Does this experiment still need more participants?
"The listing for this clinical trial on clinicaltrials.gov reveals that the study is not presently looking for new participants. This particular research project was first posted on April 1st, 2008 and was last edited on May 28th of the same year. There are, however, 213 other trials enrolling patients at this time."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger